[(Name of Issuer) Common Stock (Title of Class of Securities) P8696W104 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statement) [X] Rule 13d-1(b) [ ] Rule 13d-1(c) [ ] Rule 13d-1(d) * CUSIP No. P8696W104 1. NAMES OF REPORTING PERSONS 2. CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP 3. SEC USE ONLY]
[SCHEDULE 13D (Rule 13d-101) (Amendment No. __) SINOVAC BIOTECH LTD. (Name of Issuer) Common Shares (Title of Class Of Securities) P8696W104 (CUSIP Number) Linda Crouch-McCreadie Baker, Donelson, Bearman, Caldwell & Berkowitz, PC 100 Medtech Parkway, Suite 200 Johnson City, Tennessee 37604 (423) 928-0181 (Name, Address and Telephone Numbers of Person Authorized to Receive Notices and Communications) December 27, 2012 (Date]
[SCHEDULE 13D (Rule 13d-101) (Amendment No. __) SINOVAC BIOTECH LTD. (Name of Issuer) Common Shares (Title of Class Of Securities) P8696W104 (CUSIP Number) Linda Crouch-McCreadie Baker, Donelson, Bearman, Caldwell & Berkowitz, PC 100 Medtech Parkway, Suite 200 Johnson City, Tennessee 37604 (423) 928-0181 (Name, Address and Telephone Numbers of Person Authorized to Receive Notices and Communications) December 27, 2012 (Date]
[Sinovac Reports Unaudited Third Quarter 2012 Financial Results – Conference call scheduled for Thursday, November 15, 2012 at 8:00 AM EST– Beijing – November 15, 2012 – Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of vaccines in China, announced today its unaudited financial results for the third quarter ended September 30, 2012. Third Quarter 2012 Financial Highlights (year-over-year comparisons] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F X ___ Form 40-F _________ SINOVAC BIOTECH LTD. Weidong Yin Chairman and Chief Executive Officer 6-K 1 v328746_6k.htm FORM 6-K]
[Sinovac Reports Unaudited Third Quarter 2012 Financial Results – Conference call scheduled for Thursday, November 15, 2012 at 8:00 AM EST– Beijing – November 15, 2012 – Sinovac Biotech Ltd. (NASDAQ: SVA), a leading provider of vaccines in China, announced today its unaudited financial results for the third quarter ended September 30, 2012. Third Quarter 2012 Financial Highlights (year-over-year comparisons] [SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China Form 20-F X ___ Form 40-F _________ SINOVAC BIOTECH LTD. Weidong Yin Chairman and Chief Executive Officer 6-K 1 v328746_6k.htm FORM 6-K]
[Sinovac Reports Unaudited Second Quarter 2012 Financial Results - Conference call scheduled for Wednesday, August 15, 2012 at 8:00 AM EDT - BEIJING, Aug. 15, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (the company) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter financial results for the period ended June 30, 2012. Sinovac is] []
[Sinovac Reports Unaudited Second Quarter 2012 Financial Results - Conference call scheduled for Wednesday, August 15, 2012 at 8:00 AM EDT - BEIJING, Aug. 15, 2012 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (the company) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter financial results for the period ended June 30, 2012. Sinovac is] []
[Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention (Beijing CDC) to supply seasonal influenza vaccine to the citizens of Beijing. Dr. Weidong Yin, Chairman, President] [Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility Sinovac Biotech Ltd. (SVA), a leading China-based vaccine manufacturer, announced today that it has received GMP certification from the China State Food and Drug Administration (SFDA) for the Company's dedicated mumps vaccine production plant at its Sinovac Dalian facility. The SFDA issued a public announcement on September 12, 2012, stating] [Sinovac Awarded Tenders in Beijing and Shanghai to Supply Inactivated Hepatitis A Vaccine Healive® Under Expanded Immunization Program SVA BEIJING, Sept. 25, 2012 -- Sinovac Biotech Ltd. ( Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, "We are pleased to have been selected as the sole supplier of the inactivated hepatitis A vaccine in prefilled syringe in both] []
[Sinovac Receives Beijing CDC Tender Award to Supply Seasonal Flu Vaccine Anflu(R) to Beijing Citizens Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that it has been selected by the Beijing Centers for Disease Control and Prevention (Beijing CDC) to supply seasonal influenza vaccine to the citizens of Beijing. Dr. Weidong Yin, Chairman, President] [Sinovac Biotech Receives GMP Certification for Mumps Vaccine Production Facility Sinovac Biotech Ltd. (SVA), a leading China-based vaccine manufacturer, announced today that it has received GMP certification from the China State Food and Drug Administration (SFDA) for the Company's dedicated mumps vaccine production plant at its Sinovac Dalian facility. The SFDA issued a public announcement on September 12, 2012, stating] [Sinovac Awarded Tenders in Beijing and Shanghai to Supply Inactivated Hepatitis A Vaccine Healive® Under Expanded Immunization Program SVA BEIJING, Sept. 25, 2012 -- Sinovac Biotech Ltd. ( Mr. Weidong Yin, Chairman, President and CEO of Sinovac, commented, "We are pleased to have been selected as the sole supplier of the inactivated hepatitis A vaccine in prefilled syringe in both] []
[Sinovac Holds 2012 Annual General Meeting of Shareholders BEIJING, Aug. 23, 2012 /PRNewswire-Asia/ -- Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today that it held its 2012 Annual General Meeting of Shareholders on Wednesday, August 22, 2012 at 9:00 a.m. Beijing Time. The required quorum, a majority of the common shares outstanding, was voted] []
